Jose Ramirez
About Jose Ramirez
Jose Ramirez is an Executive Cell Therapy Account Specialist with extensive experience in the pharmaceutical and biotechnology sectors. He has a background in sales related to Infectious Disease, Rheumatology, Allergy, and Asthma, and has held positions at notable companies including Gilead Sciences and Eli Lilly.
Work at Kite Pharma
Jose Ramirez has been employed at Kite Pharma as an Executive Cell Therapy Account Specialist since 2020. His role involves managing accounts related to cell therapy, focusing on the promotion and education of innovative treatment options. Kite Pharma specializes in developing advanced therapies for cancer, and Ramirez contributes to the company's mission by leveraging his extensive experience in the pharmaceutical industry.
Education and Expertise
Jose Ramirez earned a Bachelor of Arts in Communications from California State University-Dominguez Hills. His educational background supports his expertise in sales and communication within the pharmaceutical and biotechnology sectors. He has developed a strong skill set in sales, particularly in areas such as Infectious Disease, Rheumatology, Allergy, and Asthma.
Background in Pharmaceutical Sales
Jose Ramirez has a robust background in pharmaceutical sales, with over 19 years of experience in the industry. He began his career at sanofi-aventis as a Senior Sales Representative from 2001 to 2006. He then worked at Eli Lilly and Company as an Osteoporosis Specialty Representative from 2006 to 2008, followed by a significant tenure at Gilead Sciences as an HIV Executive Therapeutic Specialist from 2008 to 2020.
Career Progression
Throughout his career, Jose Ramirez has held various positions that demonstrate his growth in the pharmaceutical sales field. After starting at sanofi-aventis, he transitioned to Eli Lilly and Company, where he focused on osteoporosis. His role at Gilead Sciences as an HIV Executive Therapeutic Specialist lasted 12 years, during which he gained significant expertise before moving to Kite Pharma.